Literature DB >> 10146879

Economic and quality-of-life aspects of treating small cell lung cancer.

P Graham1, J Boyages.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 10146879     DOI： 10.2165/00019053-199303060-00004

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  37 in total

1.  Quality-of-life assessment in small cell lung cancer.

Authors:  P Fayers
Journal:  Pharmacoeconomics       Date:  1992-09       Impact factor: 4.981

2.  Principles involved in costing.

Authors:  D B Evans
Journal:  Med J Aust       Date:  1990-08-06       Impact factor: 7.738

Review 3.  Quality-of-life assessment in cancer treatment protocols: research issues in protocol development.

Authors:  C C Gotay; E L Korn; M S McCabe; T D Moore; B D Cheson
Journal:  J Natl Cancer Inst       Date:  1992-04-15       Impact factor: 13.506

Review 4.  The crisis in health care cost in the United States: some implications for radiation oncology.

Authors:  G E Hanks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

5.  The relative value of conventional staging procedures for developing prognostic models in extensive-stage small-cell lung cancer.

Authors:  R G Sheehan; E P Balaban; J V Cox; E P Frenkel
Journal:  J Clin Oncol       Date:  1990-12       Impact factor: 44.544

6.  Small cell lung cancer: single agents revisited.

Authors:  P I Clark; M L Slevin
Journal:  Respir Med       Date:  1989-09       Impact factor: 3.415

7.  Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party.

Authors: 
Journal:  Respir Med       Date:  1989-01       Impact factor: 3.415

8.  Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial results.

Authors:  B E Hillner; T J Smith; C E Desch
Journal:  JAMA       Date:  1992-04-15       Impact factor: 56.272

9.  Nonmedical costs to patients and their families associated with outpatient chemotherapy.

Authors:  P S Houts; A Lipton; H A Harvey; B Martin; M A Simmonds; R H Dixon; S Longo; T Andrews; R A Gordon; J Meloy
Journal:  Cancer       Date:  1984-06-01       Impact factor: 6.860

10.  Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party.

Authors: 
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640
View more
  2 in total

1.  Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers.

Authors:  Sudeep J Karve; Gregory L Price; Keith L Davis; Gerhardt M Pohl; Emily Nash Smyth; Lee Bowman
Journal:  BMC Health Serv Res       Date:  2014-11-13       Impact factor: 2.655

2.  Economics of the clinical management of lung cancer in France: an analysis using a Markov model.

Authors:  C Chouaïd; L Molinier; C Combescure; J P Daurès; B Housset; A Vergnenègre
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.